Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Sponsor: Draig Therapeutics Ltd
Summary
In this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. A placebo looks the drug but contains no medicine. Subjects will attend the clinic for complete general health checks and to complete questionnaires.
Official title: A Phase 2 Double-blind, Randomised, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults With Major Depressive Disorder Receiving Pharmacological Therapy for Depression
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
118
Start Date
2026-05
Completion Date
2027-05
Last Updated
2026-05-28
Healthy Volunteers
No
Conditions
Interventions
DT-101
DT-101
Placebo
Placebo
Locations (2)
Draig Clinical Site
DeSoto, Texas, United States
Draig Clinical Site
Miami, Texas, United States